Intracellular and Plasma Pharmacokinetics of Saquinavir-Ritonavir, Administered at 1,600/100 Milligrams Once Daily in Human Immunodeficiency Virus-Infected Patients

Ritonavir-boosted saquinavir (SQV/r) is currently licensed as a twice-daily regimen. Reducing the pill burden with once-daily dosing may improve adherence. Intracellular concentrations of drugs must be related to the clinical efficacy of protease inhibitors. The aims of the study were to determine t...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ford, Jennifer, Boffito, Marta, Wildfire, Adrian, Hill, Andrew, Back, David, Khoo, Saye, Nelson, Mark, Moyle, Graeme, Gazzard, Brian, Pozniak, Anton
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2004
Témata:
Antiviral Agents
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC434222/
https://ncbi.nlm.nih.gov/pubmed/15215085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.7.2388-2393.2004
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky